Background The COVID-19 pandemic has profoundly affected endoscopy services including pancreatobiliary (PB) endoscopy across the UK. The British Society of Gastroenterology and Joint Advisory Group have issued guidance for managing endoscopy services safely throughout this period. There have been perceived concerns among the PB endoscopists that wearing full personal protective equipment might have an adverse impact on key performance indicators (KPIs) in endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS) procedures leading to non-compliance with the national guidelines. The aim of the study was to assess the impact of COVID-19 pandemic on KPIs in ERCP and EUS and ascertain the risk of procedure-related complications. Methods A retrospective audit of a prospectively maintained endoscopy database was carried out between 18 March and 31 July 2020. Results 146 ERCP procedures (common bile duct (CBD) cannulation rate of naïve papilla 89.2%, complete CBD stone extraction rate at first ERCP 88.2%, biliary stricture decompression rate 91%) and 87 EUS procedures (diagnostic accuracy of EUS-fine needle aspiration 92%) were carried out during this period. ERCP-related complications included pancreatitis (4.8%), bleeding (0.68%) and cholangitis (0.68%). 30-day ERCP procedure-related mortality was 0.68%. There were no complications or procedure-related mortality in the EUS group. Conclusion This is the first study looking at the impact of COVID-19 on KPIs and procedure-related complications in ERCP and EUS in the literature. Our study confirms that a high-quality PB endoscopy service can be delivered safely and effectively during the COVID-19 pandemic. All data relevant to the study are included in the article or uploaded as supplementary information. We agree to the data policy and are happy for you to publish in the journal if deemed suitable for publication.

中文翻译：

---

COVID-19 大流行对胰胆内窥镜检查关键绩效指标的影响：确定优先顺序、最大限度降低风险、保持范围界定和培训


背景 COVID-19 大流行深刻影响了英国各地的内窥镜检查服务，包括胰胆 (PB) 内窥镜检查。英国胃肠病学会和联合咨询小组发布了在此期间安全管理内窥镜检查服务的指南。 PB 内镜医师担心，穿戴全套个人防护装备可能会对内镜逆行胰胆管造影 (ERCP) 和内镜超声 (EUS) 手术的关键绩效指标 (KPI) 产生不利影响，导致不遵守国家指南。该研究的目的是评估 COVID-19 大流行对 ERCP 和 EUS 关键绩效指标的影响，并确定手术相关并发症的风险。方法 对 2020 年 3 月 18 日至 7 月 31 日期间前瞻性维护的内窥镜数据库进行回顾性审计。 结果 146 例 ERCP 手术（首次 ERCP 胆总管 (CBD) 插管率 89.2%，首次 ERCP 完全 CBD 结石取出率 88.2%）在此期间进行了87例EUS检查（EUS-细针抽吸诊断准确率92%），胆道狭窄减压率91%。 ERCP相关并发症包括胰腺炎（4.8%）、出血（0.68%）和胆管炎（0.68%）。 30 天 ERCP 手术相关死亡率为 0.68%。 EUS 组没有出现并发症或手术相关死亡。结论 这是文献中第一项探讨 COVID-19 对 ERCP 和 EUS 的 KPI 和手术相关并发症的影响的研究。我们的研究证实，在 COVID-19 大流行期间可以安全有效地提供高质量的 PB 内窥镜检查服务。 与研究相关的所有数据都包含在文章中或作为补充信息上传。我们同意数据政策，并且很高兴您在认为适合发表的情况下在期刊上发表文章。